Process of hepatic metastasis from pancreatic cancer: biology with clinical significance Haojun ShiJi LiDeliang Fu Review – Cancer Research 07 August 2015 Pages: 1137 - 1161
p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer Sabine HeubleinSabina K. PageUdo Jeschke Original Article – Cancer Research 02 March 2016 Pages: 1163 - 1170
Evaluation of polymorphisms in angiogenesis-related genes as predictive and prognostic markers for sunitinib-treated metastatic renal cell carcinoma patients Juana DornbuschMartina WalterSusanne Fuessel Original Article – Cancer Research 03 March 2016 Pages: 1171 - 1182
Enhancement of antitumor activity of the oxazaphosphorine cytostatic SUM-IAP by N-methylformamide G. Voelcker Original Article – Cancer Research 03 March 2016 Pages: 1183 - 1189
Proteomic study of benign and malignant pleural effusion Hongqing LiZhonghao TangWeiping Jiang Original Article – Cancer Research 05 March 2016 Pages: 1191 - 1200
MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1 Zhijun MaYulan MaKaixiong Tao Original Article – Cancer Research 08 March 2016 Pages: 1201 - 1212
MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5 Alexander I. DamanakisSabine EckhardtPietro Di Fazio Original Article – Cancer Research 09 March 2016 Pages: 1213 - 1220
SOX2 inhibits metastasis in gastric cancer Yansu ChenYefei HuangJianwei Zhou Original Article – Cancer Research 09 March 2016 Pages: 1221 - 1230
Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin) Seung Tae KimSoomin AhnJoon Oh Park Original Article – Cancer Research 16 March 2016 Pages: 1231 - 1237
Unsupervised analysis reveals two molecular subgroups of serous ovarian cancer with distinct gene expression profiles and survival Katarzyna M. LisowskaMagdalena OlbrytJolanta Kupryjańczyk Original Article – Cancer Research Open access 30 March 2016 Pages: 1239 - 1252
DNA cytophotometric and histological analysis of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced precancerous lesions of the bladder urothelium Hans Helmut DahmClaudia von der HaarHerbert Rübben Original Article – Cancer Research Open access 31 March 2016 Pages: 1253 - 1260
Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b Regina MaushagenStefan ReersBarbara Wollenberg Original Article – Cancer Research 01 April 2016 Pages: 1261 - 1271
Skin cancer prevention practices among malignant melanoma survivors: a systematic review Vinayak K. NaharM. Allison FordMartha A. Bass Review – Clinical Oncology 07 December 2015 Pages: 1273 - 1283
Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer Heng FanZhen-Yi ShaoNai-Qing Zhao Original Article - Clinical Oncology 11 February 2016 Pages: 1285 - 1297
Macroscopic morphology for estimation of malignant potential in pancreatic neuroendocrine neoplasm Eriko KatsutaAtsushi KudoMinoru Tanabe Original Article – Clinical Oncology 17 February 2016 Pages: 1299 - 1306
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis W. RabitschM. BojicW. Lamm Original Article – Clinical Oncology Open access 26 February 2016 Pages: 1307 - 1314
Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial Ying-Chun XuQi XuHong-Xia Wang Original Article – Clinical Oncology 03 March 2016 Pages: 1315 - 1323
Efficacy of EGFR tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations in China Jianlin XuYanwei ZhangBaohui Han Original Article – Clinical Oncology 04 March 2016 Pages: 1325 - 1330
Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998–2013): a population-based analysis M. RottmannT. BeckJ. Engel Original Article – Clinical Oncology 14 March 2016 Pages: 1331 - 1341
Incidence and risk factors for morbidity and mortality in elderly head and neck cancer patients undergoing major oncological surgery Shin Hyuk YooJong-Lyel RohSang Yoon Kim Original Article – Clinical Oncology 16 March 2016 Pages: 1343 - 1351
Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands N. Haj MohammadN. BernardsH. W. M. van Laarhoven Original Article – Clinical Oncology Open access 19 March 2016 Pages: 1353 - 1360
The predictive role of ADC values in prostate cancer patients treated with carbon-ion radiotherapy: initial clinical experience at Shanghai Proton and Heavy Ion Center (SPHIC) Wei-Xiang QiQing ZhangShen Fu Original Article – Clinical Oncology 23 March 2016 Pages: 1361 - 1367
Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer Gilda SchmidtChristoph GerlingerErich-Franz Solomayer Original Article – Clinical Oncology 23 March 2016 Pages: 1369 - 1376
Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer Bo Young OhYoon Ah ParkHee Cheol Kim Original Article – Clinical Oncology 24 March 2016 Pages: 1377 - 1385
Cutaneous angiosarcoma of the head and face: a single-center analysis of treatment outcomes in 43 patients in Japan Takamichi ItoHiroshi UchiMasutaka Furue Original Article – Clinical Oncology 25 March 2016 Pages: 1387 - 1394